FIELD: medicine; spectral analysis.
SUBSTANCE: immunoglobulin preparations for intravenous injection are added to biological fluids' samples. After preliminary incubation, samples having object of protection effect are incubated. Then intensity of chemoluminescence of samples is determined. Method allows revealing level of activating influence of immunoglobulin preparations onto protective ability of phagocytes for using those preparations for treating infected patients.
EFFECT: improved reliability.
2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ANTI-INFLAMMATORY ACTIVITY DETERMINATION OF IMMUNOGLOBULINS INTRAVENOUS PREPARATIONS | 2007 |
|
RU2331885C1 |
| METHOD FOR ASSESSMENT OF FUNCTIONAL ABILITY OF PHAGOCYTES | 2011 |
|
RU2445626C1 |
| BIOCHEMILUMINESCENT METHOD FOR EVALUATION OF PHAGOCYTIC ACTIVITY OF NEUTROPHILS | 2007 |
|
RU2366953C2 |
| METHOD FOR CORRECTION OF INNATE AND ADAPTIVE IMMUNITY FACTORS DYSFUNCTION FOR CHRONIC RENAL FAILURE IN EXPERIMENT | 2015 |
|
RU2616213C2 |
| 2-[6-METHYL-4-(TIETANE-3-YLOXY)PYRIMIDINE-2-YLTHIO] ACETIC ACID METHYLIDENHYDRAZIDE WITH ANTIOXIDANT ACTIVITY | 2016 |
|
RU2626651C1 |
| 6-METHYL-1-(THIETANYL-3)URACIL STIMULATING PROTECTIVE ACTIVITY OF PHAGOCYTES | 2012 |
|
RU2485118C1 |
| METHOD OF DETERMINING ANTIOXIDANT ACTIVITY OF CHEMICAL COMPOUNDS | 0 |
|
SU1532869A1 |
| METHOD TO DETERMINE NEUTROPHIL CAPACITY TO PRODUCE ACTIVATED OXYGEN METABOLITES IN EXPERIMENT | 1993 |
|
RU2089907C1 |
| METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN CHRONIC PURULENT RHINOSINUSITIS | 2008 |
|
RU2379050C2 |
